Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer
- PMID: 17465225
Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer
Abstract
Background: Cul-4, a member of the Caenorhabditis elegans "cullin" ubiquitin-ligase gene family, plays a critical role in regulation of DNA-replication in this nematode. It has been suggested that cul-4 might have an important role in the development and progression of human cancer, but no data on this subject exist. The aim of this study was to investigate the expression and prognostic relevance of CUL-4 protein in lymph node-negative breast cancer, one of the most common malignancies worldwide.
Materials and methods: CUL-4 protein expression was determined with immunohistochemistry in 167 specimens of human node-negative invasive breast cancer with long-term follow-up. Results were correlated with overall and disease-free survival of patients.
Results: Strong expression of CUL-4 protein was observed in 32 cases (19.2%), moderate expression in 59 (35.3%), weak expression in 64 (38.3%), and in 12 tumors (7.2%) no expression of CUL4 was observed. Patients with strong expression of CUL4 had a significantly shorter overall and disease-free survival (p = 0.04 and p = 0.029, respectively; Cox regression) compared to all other cases.
Conclusion: Our data provide evidence for the first time that CUL-4 could play an important role in the development and progression of human cancer.
Similar articles
-
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.Am J Pathol. 1998 Mar;152(3):721-8. Am J Pathol. 1998. PMID: 9502414 Free PMC article.
-
Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer.Cancer Res. 2002 Feb 1;62(3):632-5. Cancer Res. 2002. PMID: 11830510
-
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.Breast Cancer Res Treat. 2005 Feb;89(3):215-20. doi: 10.1007/s10549-004-0714-4. Breast Cancer Res Treat. 2005. PMID: 15754118
-
Increased expression of osteopontin in patients with triple-negative breast cancer.Eur J Clin Invest. 2008 Jun;38(6):438-46. doi: 10.1111/j.1365-2362.2008.01956.x. Epub 2008 Apr 30. Eur J Clin Invest. 2008. PMID: 18452545
-
[Expression and prognostic value of transcriptional factor sp1 in breast cancer].Ai Zheng. 2007 Sep;26(9):996-1000. Ai Zheng. 2007. PMID: 17927860 Chinese.
Cited by
-
A new layer of degradation mechanism for PR-Set7/Set8 during cell cycle.Cell Cycle. 2016 Nov 16;15(22):3042-3047. doi: 10.1080/15384101.2016.1234552. Epub 2016 Sep 20. Cell Cycle. 2016. PMID: 27649746 Free PMC article.
-
The role and mechanism of CRL4 E3 ubiquitin ligase in cancer and its potential therapy implications.Oncotarget. 2015 Dec 15;6(40):42590-602. doi: 10.18632/oncotarget.6052. Oncotarget. 2015. PMID: 26460955 Free PMC article. Review.
-
Proliferation defects and genome instability in cells lacking Cul4A.Oncogene. 2009 Jul 2;28(26):2456-65. doi: 10.1038/onc.2009.86. Epub 2009 May 11. Oncogene. 2009. PMID: 19430492 Free PMC article.
-
Clinical significance of CUL4A in human prostate cancer.Tumour Biol. 2015 Nov;36(11):8553-8. doi: 10.1007/s13277-015-3580-2. Epub 2015 Jun 3. Tumour Biol. 2015. Retraction in: Tumour Biol. 2017 Apr 20. doi: 10.1007/s13277-017-5487-6. PMID: 26036759 Retracted.
-
CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases.Open Biol. 2014 Feb 12;4(2):130217. doi: 10.1098/rsob.130217. Open Biol. 2014. PMID: 24522884 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical